North America Clinical Nutrition Market Outlook, 2029

The North America Clinical Nutrition Market is estimated to reach USD 32 billion by 2032, driven by rise in healthcare spending.

According to publisher, The North American clinical nutrition market is a flourishing sector providing specialized dietary solutions for individuals with medical conditions or those unable to meet their nutritional needs through regular diet. This report delves into the market's value, growth drivers, dynamics, segmentation, regional variations within North America, key advancements, and the competitive landscape. Market Insights

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Market Value and Growth: The North American clinical nutrition market is estimated to reach USD 32 billion by 2032, growing at a CAGR (Compound Annual Growth Rate) of over 9%. This growth is fueled by an aging population, rising healthcare expenditure, and increasing awareness of the role of nutrition in recovery. Growth Drivers: Several factors are propelling the North American market forward: Burgeoning Elderly Population:

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

North America has a rapidly growing elderly population, particularly in the United States, where the number of individuals aged 65 and above is expected to reach 80 million by 2040. This population is more susceptible to age-related conditions like malnutrition, increasing the demand for clinical nutrition products. Example: Specialized high-protein formulas can help elderly individuals maintain muscle mass and improve overall health. Rising Chronic Disease Prevalence: North America faces a significant burden of chronic diseases like diabetes, heart disease, and cancer. Clinical nutrition plays a crucial role in managing these conditions by providing targeted nutritional support. Example: Enteral feeding tubes can be used for patients with digestive issues or undergoing cancer treatment, ensuring they receive the necessary nutrients for recovery. Growing Healthcare Spending: North American countries have high healthcare spending, with a significant portion dedicated to managing chronic diseases. This allows for greater investment in clinical nutrition products and services. Example: Insurance companies in the US might cover the cost of enteral feeding supplies for patients who require them at home. Market Dynamics

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

The North American clinical nutrition market is a dynamic environment influenced by several key trends: Focus on Value-Based Care: The healthcare system in North America is shifting towards value-based care models, which emphasize cost-effectiveness and improved patient outcomes. Clinical nutrition plays a role in this by preventing complications and reducing hospital readmission rates. Example: Hospitals might invest in personalized nutrition plans using clinical nutrition products to help patients recover faster and avoid hospital re-admissions. Advancements in Telehealth: Telehealth platforms are playing an increasingly important role in clinical nutrition management. Dietitians can remotely monitor patients and provide dietary consultations. Example: A patient recovering from surgery might connect with a dietitian virtually who can assess their nutritional needs and recommend oral nutritional supplements to support recovery. Emphasis on Home Care: An aging population and rising healthcare costs are driving a trend towards home-based care. This creates a demand for convenient and portable clinical nutrition solutions. Example: Companies are developing easy-to-use enteral feeding pumps and pre-filled nutritional formulas suitable for home care settings. Market Segments The North American clinical nutrition market can be segmented based on various criteria: Product Type: The market offers a wide range of clinical nutrition products, including enteral nutrition (delivered directly into the digestive system), parenteral nutrition (delivered intravenously), and oral nutritional supplements (consumed orally). Application: Clinical nutrition products cater to various medical conditions, such as malnutrition, cancer, gastrointestinal disorders, and metabolic diseases. Regional Analysis While North America functions as a single market, there are variations in terms of market size and product preferences: The United States: The United States holds the dominant market share due to its large population, high healthcare spending, and established healthcare infrastructure. Example: The US market sees a high demand for enteral feeding products for patients in hospitals and long-term care facilities. Canada: Canada has a smaller market but is experiencing growth due to a similar aging population and increasing government support for home-based care. Example: Canadian healthcare providers might focus on offering oral nutritional supplements to manage chronic diseases in an outpatient setting. Key Developments The North American clinical nutrition market is experiencing continuous innovation: Artificial Intelligence (AI) Integration: AI is being explored to personalize nutrition plans and predict patient needs. Example: An AI-powered platform might analyze a patient's medical history and recommend specific clinical nutrition products based on their individual requirements. Focus on Sustainability: Manufacturers are exploring ways to develop sustainable packaging and production methods for clinical nutrition products. Rise of Direct-to-Consumer Models: There's an emergence of direct-to-consumer (D2C) models for clinical nutrition products, particularly for oral nutritional supplements. This allows for convenient online purchase and delivery. Example: A company might offer a subscription service for personalized oral nutritional supplements delivered directly to the customer's doorstep. Competitive Landscape The North American clinical nutrition market is a competitive landscape with established players and emerging companies: Multinational Pharmaceutical Companies: Major pharmaceutical companies like Nestle, Abbott Laboratories, and Baxter International are key players, offering a wide range of clinical nutrition products. Example: Abbott Laboratories offers a variety of enteral feeding formulas and delivery systems for patients with different medical needs. Specialized Nutrition Companies: Specialized companies like Fresenius Kabi and Danone Nutricia focus exclusively on clinical nutrition products, catering to specific patient needs. Example: Fresenius Kabi offers a range of parenteral nutrition solutions for patients who cannot tolerate enteral feeding. Emerging Startups: Innovative startups are developing new and specialized clinical nutrition solutions, such as targeted nutrient formulas or meal replacement products catering to specific conditions. Example: A startup might develop a line of oral nutritional supplements enriched with specific vitamins and minerals to address deficiencies in elderly individuals. Healthcare Providers: In some cases, hospitals and healthcare institutions might develop or partner with manufacturers to produce their own clinical nutrition products to meet specific patient needs.Example: A hospital system might develop a line of enteral feeding formulas customized for specific patient populations within their facilities. The North American clinical nutrition market is poised for continued growth. With an aging population, rising chronic diseases, and a focus on value-based care and remote patient management, the demand for innovative and effective clinical nutrition solutions is expected to remain strong. As technology advances and healthcare delivery models evolve, the North American market promises to be at the forefront of advancements in clinical nutrition.

Table of Contents

  • 1 Introduction 9
  • 1.1 Industry Definition and Research Scope 9
  • 1.1.1 Industry Definition 9
  • 1.1.2 Research Scope 10
  • 1.2 Research Methodology 13
  • 1.2.1 Overview of Market Research Methodology 13
  • 1.2.2 Market Assumption 14
  • 1.2.3 Secondary Data 14
  • 1.2.4 Primary Data 14
  • 1.2.5 Data Filtration and Model Design 15
  • 1.2.6 Market Size/Share Estimation 16
  • 1.2.7 Research Limitations 17
  • 1.3 Executive Summary 18
  • 2 Market Overview and Dynamics 21
  • 2.1 Market Size and Forecast 21
  • 2.1.1 Impact of COVID-19 on World Economy 22
  • 2.1.2 Impact of COVID-19 on the Market 25
  • 2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 27
  • 2.2 Major Growth Drivers 31
  • 2.3 Market Restraints and Challenges 37
  • 2.4 Emerging Opportunities and Market Trends 40
  • 2.5 Porter’s Fiver Forces Analysis 44
  • 3 Segmentation of North America Market by Substrate 48
  • 3.1 Market Overview by Substrate 48
  • 3.2 Carbohydrates 50
  • 3.3 Lipids 51
  • 3.4 Proteins & Amino Acids 52
  • 3.5 Water & Electrolyte 53
  • 3.6 Dietary Fiber 54
  • 3.7 Antioxidants 55
  • 3.8 Other Substrates 56
  • 4 Segmentation of North America Market by Administration Route 57
  • 4.1 Market Overview by Administration Route 57
  • 4.2 Oral or Enteral Administration 59
  • 4.2.1 Oral Nutrition Supplements 60
  • 4.2.2 Tube Feeding 61
  • 4.3 Parenteral Administration 62
  • 4.3.1 Supplemental Parenteral Nutrition 64
  • 4.3.2 Total Parenteral Nutrition 65
  • 4.3.3 All-in-One System 66
  • 4.3.4 Multiple Bottle System 67
  • 5 Segmentation of North America Market by Dosage Form 68
  • 5.1 Market Overview by Dosage Form 68
  • 5.2 Powder 70
  • 5.3 Liquid 71
  • 5.4 Solid and Semi-solid 72
  • 6 Segmentation of North America Market by Therapeutic Area 73
  • 6.1 Market Overview by Therapeutic Area 73
  • 6.2 Malnutrition 75
  • 6.3 Metabolic Disorders 76
  • 6.4 Gastrointestinal Disorders 77
  • 6.5 Cancer 78
  • 6.6 Neurology 79
  • 6.7 Renal Diseases 80
  • 6.8 Respiratory Diseases 81
  • 6.9 Other Therapeutic Areas 82
  • 7 Segmentation of North America Market by End User 83
  • 7.1 Market Overview by End User 83
  • 7.2 Infant 85
  • 7.3 Children 86
  • 7.4 Adult 87
  • 7.5 Geriatrics 88
  • 8 Segmentation of North America Market by Healthcare Setting 89
  • 8.1 Market Overview by Healthcare Setting 89
  • 8.2 Hospitals 91
  • 8.3 Long-term Care Facilities (LTC) 92
  • 8.4 Homecare 93
  • 8.5 Inpatient Rehabilitation Facilities 94
  • 8.6 Other Healthcare Settings 95
  • 9 Segmentation of North America Market by Distribution Channel 96
  • 9.1 Market Overview by Distribution Channel 96
  • 9.2 Institutional Sales 98
  • 9.3 Supermarkets & Hypermarkets 99
  • 9.4 Pharmacies 100
  • 9.5 Drug Stores 101
  • 9.6 Online Channels 102
  • 9.7 Other Distribution Channels 103
  • 10 North America Market 2022-2032 by Country 104
  • 10.1 Overview of North America Market 104
  • 10.2 U.S. 107
  • 10.3 Canada 110
  • 10.4 Mexico 112
  • 11 Competitive Landscape 114
  • 11.1 Overview of Key Vendors 114
  • 11.2 New Product Launch, Partnership, Investment, and M&A 117
  • 11.3 Company Profiles 118
  • Abbott Nutrition 118
  • B Braun Melsungen Ag 120
  • BASF SE 123
  • Baxter International Inc. 126
  • Claris Lifesciences Ltd. 129
  • Fresenius Kabi Ag 130
  • Lonza Group AG 133
  • Nestlé S.A. 137
  • Nutricia Ltd 142
  • Perrigo Company Plc 146
  • RELATED REPORTS 149



Table 1. Snapshot of North America Clinical Nutrition Market in Balanced Perspective, 2022-2032 19
Table 2. World Economic Outlook, 2021-2031 23
Table 3. World Economic Outlook, 2021-2023 24
Table 4. Scenarios for Economic Impact of Ukraine Crisis 28
Table 5. World Health Spending by Region, $ bn, 2013-2020 36
Table 6. Main Product Trends and Market Opportunities in North America Clinical Nutrition Market 40
Table 7. North America Clinical Nutrition Market by Substrate, 2022-2032, $ mn 48
Table 8. North America Clinical Nutrition Market by Administration Route, 2022-2032, $ mn 57
Table 9. North America Clinical Nutrition Market: Oral or Enteral Administration by Type, 2022-2032, $ mn 59
Table 10. North America Clinical Nutrition Market: Parenteral Administration by Type, 2022-2032, $ mn 63
Table 11. North America Clinical Nutrition Market by Dosage Form, 2022-2032, $ mn 68
Table 12. North America Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn 73
Table 13. North America Clinical Nutrition Market by End User, 2022-2032, $ mn 83
Table 14. North America Clinical Nutrition Market by Healthcare Setting, 2022-2032, $ mn 89
Table 15. North America Clinical Nutrition Market by Distribution Channel, 2022-2032, $ mn 96
Table 16. North America Clinical Nutrition Market by Country, 2022-2032, $ mn 105
Table 17. U.S. Clinical Nutrition Market by Administration Route, 2022-2032, $ mn 109
Table 18. U.S. Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn 109
Table 19. U.S. Clinical Nutrition Market by End User, 2022-2032, $ mn 109
Table 20. Canada Clinical Nutrition Market by Administration Route, 2022-2032, $ mn 111
Table 21. Canada Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn 111
Table 22. Canada Clinical Nutrition Market by End User, 2022-2032, $ mn 111
Table 23. Mexico Clinical Nutrition Market by Administration Route, 2022-2032, $ mn 113
Table 24. Mexico Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn 113
Table 25. Mexico Clinical Nutrition Market by End User, 2022-2032, $ mn 113
Table 26. Abbott Nutrition: Company Snapshot 118
Table 27. Abbott Nutrition: Business Segmentation 119
Table 28. Abbott Nutrition: Product Portfolio 119
Table 29. B Braun Melsungen Ag: Company Snapshot 120
Table 30. B Braun Melsungen Ag: Business Segmentation 121
Table 31. B Braun Melsungen Ag: Revenue by Region 121
Table 32. B Braun Melsungen Ag: Product Portfolio 122
Table 33. BASF: Company Snapshot 123
Table 34. BASF: Business Segmentation 124
Table 35. BASF: Revenue by Region 124
Table 36. BASF: Product Portfolio 125
Table 37. Baxter International Inc.: Company Snapshot 126
Table 38. Baxter International Inc.: Business Segmentation 126
Table 39. Baxter International Inc.: Revenue by Region 127
Table 40. Baxter International Inc.: Product Portfolio 127
Table 41. Claris Lifesciences Ltd.: Company Snapshot 129
Table 42. Fresenius Kabi Ag: Company Snapshot 130
Table 43. Fresenius Kabi Ag: Business Segmentation 131
Table 44. Fresenius Kabi Ag: Revenue by Region 131
Table 45. Fresenius Kabi Ag: Product Portfolio 132
Table 46. Lonza Group: Company Snapshot 133
Table 47. Lonza Group: Business Segmentation in 2018 134
Table 48. Lonza Group: Product Portfolio 134
Table 49. Lonza Group: Revenue by Region in 2018 135
Table 50. Nestlé S.A.: Company Snapshot 137
Table 51. Nestlé S.A.: Business Segmentation 137
Table 52. Nestlé S.A.: Product Portfolio 138
Table 53. Nestlé S.A.: Revenue, 2018-2020, $ bn 140
Table 54. Nutricia Ltd: Company Snapshot 142
Table 55. Nutricia Ltd: Business Segmentation 143
Table 56. Nutricia Ltd: Revenue by Region 143
Table 57. Nutricia Ltd: Product Portfolio 144
Table 58. Perrigo Company Plc: Company Snapshot 146
Table 59. Perrigo Company Plc: Business Segmentation 147
Table 60. Perrigo Company Plc: Revenue by Region 147
Table 61. Perrigo Company Plc: Product Portfolio 147



Figure 1. Research Method Flow Chart 13
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 16
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032 18
Figure 4. North America Clinical Nutrition Market, 2022-2032, $ mn 21
Figure 5. Impact of COVID-19 on Business 25
Figure 6. Primary Drivers and Impact Factors of North America Clinical Nutrition Market 31
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million 34
Figure 8. Worldwide Geriatric Population (60 years and above) by Region, 2015 & 2030, million 35
Figure 9. Forecast of World Middle-class Population by Region, 2015-2030, million 35
Figure 10. Primary Restraints and Impact Factors of North America Clinical Nutrition Market 37
Figure 11. Investment Opportunity Analysis 41
Figure 12. Porter’s Fiver Forces Analysis of North America Clinical Nutrition Market 44
Figure 13. Breakdown of North America Clinical Nutrition Market by Substrate, 2022-2032, % of Revenue 49
Figure 14. North America Addressable Market Cap in 2023-2032 by Substrate, Value ($ mn) and Share (%) 49
Figure 15. North America Clinical Nutrition Market by Substrate: Carbohydrates, 2022-2032, $ mn 50
Figure 16. North America Clinical Nutrition Market by Substrate: Lipids, 2022-2032, $ mn 51
Figure 17. North America Clinical Nutrition Market by Substrate: Proteins & Amino Acids, 2022-2032, $ mn 52
Figure 18. North America Clinical Nutrition Market by Substrate: Water & Electrolyte, 2022-2032, $ mn 53
Figure 19. North America Clinical Nutrition Market by Substrate: Dietary Fiber, 2022-2032, $ mn 54
Figure 20. North America Clinical Nutrition Market by Substrate: Antioxidants, 2022-2032, $ mn 55
Figure 21. North America Clinical Nutrition Market by Substrate: Other Substrates, 2022-2032, $ mn 56
Figure 22. Breakdown of North America Clinical Nutrition Market by Administration Route, 2022-2032, % of Sales Revenue 58
Figure 23. North America Addressable Market Cap in 2023-2032 by Administration Route, Value ($ mn) and Share (%) 58
Figure 24. North America Clinical Nutrition Market by Administration Route: Oral or Enteral Administration, 2022-2032, $ mn 59
Figure 25. North America Clinical Nutrition Market by Oral or Enteral Administration: Oral Nutrition Supplements, 2022-2032, $ mn 60
Figure 26. North America Clinical Nutrition Market by Oral or Enteral Administration: Tube Feeding, 2022-2032, $ mn 61
Figure 27. North America Clinical Nutrition Market by Administration Route: Parenteral Administration, 2022-2032, $ mn 62
Figure 28. North America Clinical Nutrition Market by Parenteral Administration: Supplemental Parenteral Nutrition, 2022-2032, $ mn 64
Figure 29. North America Clinical Nutrition Market by Parenteral Administration: Total Parenteral Nutrition, 2022-2032, $ mn 65
Figure 30. North America Clinical Nutrition Market by Parenteral Administration: All-in-One System, 2022-2032, $ mn 66
Figure 31. North America Clinical Nutrition Market by Parenteral Administration: Multiple Bottle System, 2022-2032, $ mn 67
Figure 32. Breakdown of North America Clinical Nutrition Market by Dosage Form, 2022-2032, % of Sales Revenue 69
Figure 33. North America Addressable Market Cap in 2023-2032 by Dosage Form, Value ($ mn) and Share (%) 69
Figure 34. North America Clinical Nutrition Market by Dosage Form: Powder, 2022-2032, $ mn 70
Figure 35. North America Clinical Nutrition Market by Dosage Form: Liquid, 2022-2032, $ mn 71
Figure 36. North America Clinical Nutrition Market by Dosage Form: Solid and Semi-solid, 2022-2032, $ mn 72
Figure 37. Breakdown of North America Clinical Nutrition Market by Therapeutic Area, 2022-2032, % of Revenue 74
Figure 38. North America Addressable Market Cap in 2023-2032 by Therapeutic Area, Value ($ mn) and Share (%) 74
Figure 39. North America Clinical Nutrition Market by Therapeutic Area: Malnutrition, 2022-2032, $ mn 75
Figure 40. North America Clinical Nutrition Market by Therapeutic Area: Metabolic Disorders, 2022-2032, $ mn 76
Figure 41. North America Clinical Nutrition Market by Therapeutic Area: Gastrointestinal Disorders, 2022-2032, $ mn 77
Figure 42. North America Clinical Nutrition Market by Therapeutic Area: Cancer, 2022-2032, $ mn 78
Figure 43. North America Clinical Nutrition Market by Therapeutic Area: Neurology, 2022-2032, $ mn 79
Figure 44. North America Clinical Nutrition Market by Therapeutic Area: Renal Diseases, 2022-2032, $ mn 80
Figure 45. North America Clinical Nutrition Market by Therapeutic Area: Respiratory Diseases, 2022-2032, $ mn 81
Figure 46. North America Clinical Nutrition Market by Therapeutic Area: Other Therapeutic Areas, 2022-2032, $ mn 82
Figure 47. Breakdown of North America Clinical Nutrition Market by End User, 2022-2032, % of Revenue 84
Figure 48. North America Addressable Market Cap in 2023-2032 by End User, Value ($ mn) and Share (%) 84
Figure 49. North America Clinical Nutrition Market by End User: Infant, 2022-2032, $ mn 85
Figure 50. North America Clinical Nutrition Market by End User: Children, 2022-2032, $ mn 86
Figure 51. North America Clinical Nutrition Market by End User: Adult, 2022-2032, $ mn 87
Figure 52. North America Clinical Nutrition Market by End User: Geriatrics, 2022-2032, $ mn 88
Figure 53. Breakdown of North America Clinical Nutrition Market by Healthcare Setting, 2022-2032, % of Revenue 89
Figure 54. North America Addressable Market Cap in 2023-2032 by Healthcare Setting, Value ($ mn) and Share (%) 90
Figure 55. North America Clinical Nutrition Market by Healthcare Setting: Hospitals, 2022-2032, $ mn 91
Figure 56. North America Clinical Nutrition Market by Healthcare Setting: Long-term Care Facilities (LTC), 2022-2032, $ mn 92
Figure 57. North America Clinical Nutrition Market by Healthcare Setting: Homecare, 2022-2032, $ mn 93
Figure 58. North America Clinical Nutrition Market by Healthcare Setting: Inpatient Rehabilitation Facilities, 2022-2032, $ mn 94
Figure 59. North America Clinical Nutrition Market by Healthcare Setting: Other Healthcare Settings, 2022-2032, $ mn 95
Figure 60. Breakdown of North America Clinical Nutrition Market by Distribution Channel, 2022-2032, % of Revenue 97
Figure 61. North America Addressable Market Cap in 2023-2032 by Distribution Channel, Value ($ mn) and Share (%) 97
Figure 62. North America Clinical Nutrition Market by Distribution Channel: Institutional Sales, 2022-2032, $ mn 98
Figure 63. North America Clinical Nutrition Market by Distribution Channel: Supermarkets & Hypermarkets, 2022-2032, $ mn 99
Figure 64. North America Clinical Nutrition Market by Distribution Channel: Pharmacies, 2022-2032, $ mn 100
Figure 65. North America Clinical Nutrition Market by Distribution Channel: Drug Stores, 2022-2032, $ mn 101
Figure 66. North America Clinical Nutrition Market by Distribution Channel: Online Channels, 2022-2032, $ mn 102
Figure 67. North America Clinical Nutrition Market by Distribution Channel: Other Distribution Channels, 2022-2032, $ mn 103
Figure 68. Breakdown of North America Clinical Nutrition Market by Country, 2022 and 2032, % of Revenue 105
Figure 69. Contribution to North America 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%) 106
Figure 70. U.S. Clinical Nutrition Market, 2022-2032, $ mn 108
Figure 71. Canada Clinical Nutrition Market, 2022-2032, $ mn 110
Figure 72. Clinical Nutrition Market in Mexico, 2022-2032, $ mn 112
Figure 73. Growth Stage of North America Clinical Nutrition Industry over the Forecast Period 114
Figure 74. Nestlé S.A.: Revenue by Region, 2018 140
Logo

North America Clinical Nutrition Market Outlook, 2029

Contact usWe are friendly and approachable, give us a call.